 Radiogenomics is a new field of medical science that combines the study of radiology and genomics. It can provide valuable insights into disease progression and treatment outcomes by analyzing the relationship between genetic mutations and imaging data. Recent advances in technology have enabled the integration of radiologic and genomic data, which has led to the development of radiogenomics. The field has been particularly successful in the areas of brain tumors and breast cancer, with recent studies focusing on gastrointestinal cancer as well. Artificial intelligence, AI, is also being used to analyze large amounts of data, making radiogenomics more efficient and accurate. The future of radiogenomics lies in its ability to provide more precise diagnoses and treatments, leading to better patient outcomes. This article was authored by Asamo Hashino and Hajime Yokota.